Patents by Inventor Daniel E. Katzman
Daniel E. Katzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20110306669Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.Type: ApplicationFiled: August 22, 2011Publication date: December 15, 2011Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
-
Publication number: 20110129519Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.Type: ApplicationFiled: February 7, 2011Publication date: June 2, 2011Inventor: Daniel E. Katzman
-
Patent number: 7943632Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.Type: GrantFiled: September 30, 2005Date of Patent: May 17, 2011Assignee: NeuroHealing Pharmaceuticals, Inc.Inventors: Daniel E. Katzman, Elkan R. Gamzu, Neal M. Farber, Esteban A. Fridman, Marcelo Merello
-
Patent number: 7884135Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.Type: GrantFiled: August 13, 2007Date of Patent: February 8, 2011Assignee: NeuroHealing Pharmaceuticals, Inc.Inventor: Daniel E. Katzman
-
Publication number: 20090318559Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.Type: ApplicationFiled: August 13, 2007Publication date: December 24, 2009Inventor: Daniel E. Katzman
-
Publication number: 20090123545Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.Type: ApplicationFiled: July 21, 2006Publication date: May 14, 2009Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
-
Patent number: 6491643Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.Type: GrantFiled: January 22, 2001Date of Patent: December 10, 2002Assignee: Oridion Medical Ltd.Inventors: Daniel E. Katzman, Ephraim Carlebach
-
Publication number: 20010021815Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.Type: ApplicationFiled: January 22, 2001Publication date: September 13, 2001Inventors: Daniel E. Katzman, Ephraim Carlebach
-
Patent number: 6186958Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.Type: GrantFiled: September 10, 1998Date of Patent: February 13, 2001Assignee: Oridion MedicalInventors: Daniel E. Katzman, Ephraim Carlebach
-
Patent number: 6180414Abstract: A breath test for determining the rate of metabolism of a drug is described. First, a safe and effective amount of the drug, preferably appropriately labelled and most preferably isotopically-labelled, is administered to a subject. After a suitable time period, the exhaled breath of the subject is analyzed to determine the concentration of a metabolite. The concentration of the metabolite is then used to determine the rate of metabolism of the drug. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of determining the rate of metabolism of a drug in a subject. For example, such a breath test kit could include an isotopically-labelled drug to be administered to the subject.Type: GrantFiled: June 28, 1999Date of Patent: January 30, 2001Assignee: Oridion Medical Ltd.Inventor: Daniel E. Katzman
-
Patent number: 6067989Abstract: A breath test for diagnosing the presence of Helicobacter pylori in a subject is described. The method of diagnosing Helicobacter pylori is performed as follows. First, a safe and effective amount of urea, preferably appropriately labelled, is administered to the subject. Second, a plurality of the exhaled breaths of the subject is analyzed to detect the concentration of a cleavage product or products, produced when urease cleaves the substrate. The measured concentrations are then fitted to a curve, and the derivative is then calculated, to indicate the presence or absence of Helicobacter pylori infection in the subject.Type: GrantFiled: February 26, 1997Date of Patent: May 30, 2000Assignee: Oridion Medical, Ltd.Inventor: Daniel E. Katzman
-
Patent number: 5962335Abstract: A breath test for determining the rate of metabolism of a drug is described. First, a safe and effective amount of the drug, preferably appropriately labelled and most preferably isotopically-labelled, is administered to a subject. After a suitable time period, the exhaled breath of the subject is analyzed to determine the concentration of a metabolite. The concentration of the metabolite is then used to determine the rate of metabolism of the drug. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of determining the rate of metabolism of a drug in a subject. For example, such a breath test kit could include an isotopically-labelled drug to be administered to the subject.Type: GrantFiled: January 3, 1997Date of Patent: October 5, 1999Assignee: Oridion Medical Ltd.Inventor: Daniel E. Katzman
-
Patent number: 5944670Abstract: A breath test for diagnosing the presence of Chlamydia species, such as Chlamydia pneumoniae, in a subject is described. The method of diagnosing Chlamydia species in a subject is performed as follows. First, a safe and effective amount of a substrate, preferably appropriately labelled, is administered to the subject. Second, the exhaled breath of the subject is analyzed to detect the concentration of a cleavage product or products, produced when an enzyme from Chlamydia bacteria cleaves the substrate. The presence of the cleavage product or products indicates a positive diagnosis of Chlamydia species in the subject. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of diagnosing Chlamydia species in a subject. For example, such a breath test kit could include a substrate to be administered to the subject.Type: GrantFiled: December 2, 1996Date of Patent: August 31, 1999Assignee: Oridion Medical Ltd.Inventor: Daniel E. Katzman
-
Patent number: RE38728Abstract: A breath test analyzer, which analyzes exhaled breadths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small in that it can be easily accommodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.Type: GrantFiled: April 16, 2002Date of Patent: April 19, 2005Assignee: Oridion Medical, LTDInventors: Daniel E. Katzman, Ephraim Carlebach